Objective
As a result of demographic changes, political and social instability, air travel and globalisation, the EU is increasingly threatened by tuberculosis, a chronic respiratory disease that respects no frontiers. The current treatment requires modernisation to improve efficacy and tolerance, and to combat problems of resistance. In this project, structural and functional genomic will be used as tools for drug discovery. Mycobacterium proteins that could serve as novel targets for chemotherapy will be identified, and inhibitors will either be isolated from libraries by using novel screens of natural or (semi) synthetic products or, by using 3D structures as templates for drug design. Other products arising from this proposal include expression libraries, large amounts of mycobacterium proteins, protease and protein linkage maps, and dedicated databases.
Fields of science
- natural sciencesbiological sciencesgenetics
- medical and health sciencesbasic medicinemedicinal chemistry
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteins
- medical and health sciencesclinical medicinepneumologytuberculosis
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
Call for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
75724 Paris
France
See on map
Participants (11)
WC1E 7HX London
See on map
13288 Marseille
See on map
07745 Jena
See on map
55131 Mainz
See on map
10117 Berlin
See on map
2300 Koepenhagen
See on map
13288 Marseille
See on map
1015 Lausanne
See on map
LE1 7RH Leicester
See on map
YO10 5DD York
See on map
13288 Marseille
See on map